Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
DĂŶƵĞůŶĂƐƚĂĐŝŽ^ĄŶĐŚĞnjͲKůŝǀĂƐ1
/PWLYZLUZPIPSPKHKHStYNPJHH Martha Patricia Valencia-Zavala1
'lŽria ertha VeŐa-ZŽďleĚŽ2,4
HU[PYYL[YV]PYHSLZ!L[YH]PYPUH :eƐƷƐ lďertŽ ^Ąnchenj-KlivaƐ2
Guillermo Velázquez-Sámano3
YHS[LNYH]PY`KHY\UH]PY Guadalupe Sepúlveda-Velázquez5
1
Médico adscrito al Servicio de Alergia e Inmuno-
logía Clínica.
9,:<4,5 2
Médico de apoyo al Servicio de Alergia e Inmuno-
;VKVZSVZMmYTHJVZHU[PYYL[YV]PYHSLZ[PLULULMLJ[VZHK]LYZVZX\LW\LKLU logía Clínica.
3
Jefe del Servicio de Alergia e Inmunología Clínica.
THUPMLZ[HYZL H JVY[V V SHYNV WSHaV ,S YPLZNV KL LMLJ[VZ ZLJ\UKHYPVZ
Hospital General de México, O.D.
LZWLJxÄJVZ]HYxHKL\UMmYTHJVHV[YVKL\UHJSHZLKLTLKPJHTLU[V 4
ŽĐƚŽƌĂĞŶ/ŶŵƵŶŽůŽŐşĂ͕ĂƚĞĚƌĄƟĐĂ͘
HV[YH`KL\UWHJPLU[LHV[YV<UHTLQVYJVTWYLUZP}UKLLZ[VZLMLJ[VZ 5
YƵşŵŝĐĂ&ĄƌŵĂĐŽͲŝſůŽŐĂ͕ĞƉĂƌƚĂŵĞŶƚŽĚĞ/ŶǀĞƐ-
LZKLPU[LYtZUVZ}SVWHYHSVZLZWLJPHSPZ[HZLU=0/ZPUV[HTIPtUWHYH ƟŐĂĐŝſŶůşŶŝĐĂ͕&ĂĐƵůƚĂĚĚĞYƵşŵŝĐĂ͘
V[YVZTtKPJVZX\LH[LUKLTVZSHZYLHJJPVULZHStYNPJHZLUSVZWHJPLU[LZ hŶŝǀĞƌƐŝĚĂĚEĂĐŝŽŶĂůƵƚſŶŽŵĂĚĞDĠdžŝĐŽ͘
=0/WVZP[P]VZ*HKHMmYTHJVHU[PYYL[YV]PYHSZLHZVJPHJVUZ\ZWYVWPVZ
LMLJ[VZHK]LYZVZLZWLJxÄJVZVW\LKLJH\ZHYWYVISLTHZZ}SVLUJPYJ\UZ-
[HUJPHZWHY[PJ\SHYLZ,ULZ[LHY[xJ\SVZLYL]PZHUHSN\UVZLMLJ[VZHStYNPJVZ
HK]LYZVZKLS[YH[HTPLU[VHU[PYYL[YV]PYHSKLNYHUHJ[P]PKHK;(9.(LU
LS [YH[HTPLU[V KLS=0/ KL \U WHJPLU[L 5\LZ[YV VIQL[P]V LZ VI[LULY
\UJVUVJPTPLU[VWYmJ[PJVKLLZ[VZLMLJ[VZHK]LYZVZWYVTV]PLUKVLS
YLJVUVJPTPLU[V[LTWYHUV`SHYL]LYZP}UKLSVZLMLJ[VZHK]LYZVZNYH]LZ
`YLK\JPYSHZPU[LYHJJPVULZMHYTHJVS}NPJHZHK]LYZHZ
7HSHIYHZ JSH]L! TLKPJHTLU[VZ HU[PYYL[YV]PYHSLZ LMLJ[VZ ZLJ\UKHYPVZ
YLHJJPVULZ HStYNPJHZ [YH[HTPLU[V HU[PYYL[YV]PYHS KL NYHU HJ[P]PKHK
;(9.(
(SSLYNPJO`WLYZLUZP[P]P[`[VHU[PYL[YV]PYHS
KY\NZ!L[YH]PYPULYHS[LNYH]PYHUK
KHY\UH]PY
():;9(*;
(SSHU[PYL[YV]PYHSKY\NZJHUOH]LIV[OZOVY[[LYTHUKSVUN[LYTHK]LYZL Recibido: 12 de diciembre 2014
L]LU[Z;OLYPZRVMZWLJPÄJZPKLLMMLJ[Z]HYPLZMYVTKY\N[VKY\NMYVTKY\N Aceptado: 15 de enero 2015
JSHZZ[VKY\NJSHZZHUKMYVTWH[PLU[[VWH[PLU[(IL[[LY\UKLYZ[HUKPUNVM
[OLHK]LYZLLMMLJ[ZVMHU[PYL[YV]PYHSHNLU[ZPZVMPU[LYLZ[UV[VUS`MVY/0=
ZWLJPHSPZ[ZI\[HSZVMVYV[OLYWO`ZPJPHUZ^OVJHYLHSSLYN`YLHJ[PVUZPU Correspondencia: Dra. Martha Patricia Valencia
Zavala
/0=WVZP[P]LWH[PLU[Z,HJOHU[PYL[YV]PYHSTLKPJH[PVUPZHZZVJPH[LK^P[O
Zacatecas 44, segundo piso, consultorio 203
P[ZV^UZWLJPÄJHK]LYZLLMMLJ[ZVYTH`JH\ZLWYVISLTZVUS`PUWHY[PJ\SHY
06700 México, DF
JPYJ\TZ[HUJLZ0U[OPZHY[PJSLZVTLHK]LYZLHSSLYNPJLMMLJ[ZVM/((9;
valenciazavala@hotmail.com
[OLYHW`PU[OL[YLH[TLU[VM/0=MYVTHWH[PLU[HYLYL]PL^LK6\YHPT
PZ[VNHPUH^VYRPUNRUV^SLKNLVM[OLZLHK]LYZLLMMLJ[ZWYVTV[PUN[OL
ƐƚĞĂƌơĐƵůŽĚĞďĞĐŝƚĂƌƐĞĐŽŵŽ
LHYS`YLJVNUP[PVUHUKYL]LYZHSVMWV[LU[PHSS`ZLYPV\ZHK]LYZLLMMLJ[ZHUK
Sánchez-Klivas M, Valencia-Zavala MP, Vega-Zo-
YLK\JPUN[OLWV[LU[PHSMVYHK]LYZLKY\NPU[LYHJ[PVUZ
ďledo G, Sánchez-Klivas : LJ col. ,ipersensiďilidad
2L`^VYKZ!HU[PYL[YV]PYHSKY\NZZPKLLMMLJ[ZHSSLYN`YLHJ[PVUZ/((9; alérgica a anƟrretrovirales͗ etravirina, raltegravir LJ
[OLYHW` darunavir. Revista Alergia México 2015;62:142-148.
www.nietoeditores.com.mx
Revista
México
Sánchez-Olivas MA y col. Hipersensibilidad alérgica a antirretrovirales
Revista Alergia México Volumen 62, Núm. 2, abril-junio 2015
Revista
México
Sánchez-Olivas MA y col. Hipersensibilidad alérgica a antirretrovirales
Revista Alergia México Volumen 62, Núm. 2, abril-junio 2015
Revista
México
Sánchez-Olivas MA y col. Hipersensibilidad alérgica a antirretrovirales
VZHX\PUH]PY:PULTIHYNVZ\ZWLUKLYLS;(9.( [YH[HTPLU[VHU[PYYL[YV]PYHS`SHYHWPKLaJVUX\L
W\LKL HZVJPHYZL JVU YLIV[L KL SH YLWSPJHJP}U ZLWYVK\JLW\LKLJH\ZHYX\LLSZPZ[LTHPUT\-
KLS]PY\ZKLOLWH[P[PZ)LUWHJPLU[LZJVUJVPU- UP[HYPVZL]\LS]HOPWLYHJ[P]VJVU[YHPUMLJJPVULZ
MLJJP}UWVYLZ[L]PY\Z`LS=0/X\PLULZYLJPILU ¸Z\IJSxUPJHZ¹ X\L ZVIYL]P]LU LU LS J\LYWV SV
LZX\LTHZIHZHKVZLUSHTP]\KPUHV[LUVMV]PY,U X\L YLZ\S[H LU ZxU[VTHZ NYH]LZ ` WYVSVUNHKVZ
LZ[VZ JHZVZ WVKYxH JVUZPKLYHYZL JVU[PU\HY JVU KLSHLUMLYTLKHKSVX\LKHS\NHYHSZxUKYVTL
TVUV[LYHWPHJVU[YHLS]PY\ZKLOLWH[P[PZ)JVU PUÅHTH[VYPVKLYLJVUZ[P[\JP}UPUT\UVS}NPJHLU
\UVKLLZ[VZKVZHNLU[LZ,USHWYmJ[PJHJSxUPJH WHJPLU[LZJVU=0/
SHJHYNH]PYHSZL\[PSPaHWHYHKL[LYTPUHYLSZxU-
KYVTLJVTWH[PISLJVU\UHPUMLJJP}UHN\KHWVY CONCLUSIONES
=0/SH]HSVYHJP}UPUPJPHSKL\UHPUMLJJP}UWVY
=0/SHKLJPZP}UKLPUPJPHY[YH[HTPLU[V`JVTV ,U[YLSVZLMLJ[VZUVJP]VZJH\ZHKVZLUWHJPLU[LZ
THYJHKVYKLYLZW\LZ[H[LYHWt\[PJH3HJHYNH]PYHS JVU=0/WVYSHHKTPUPZ[YHJP}UKLHU[PYYL[YV]PYH-
LZLSTLQVYTHYJHKVYWHYHWYLKLJPYSHWYVNYLZP}U SLZLZ[mUSHZ]HYPHJPVULZJSxUPJHZWH[VS}NPJHZ`
H:0+(`SHZ\WLY]P]LUJPH3HZJPMYHZKL*+ HKHW[H[P]HZX\LZVIYL]PLULUWVYSHKPZTPU\JP}U
[PLULUTLUVY]HSVYWYVU}Z[PJVX\PamWVYX\LSVZ KLJHYNH]PYHSLSLTWLVYHTPLU[VWHYHK}QPJVKL
JHTIPVZZLWYVK\JLUJVUYL[YHZVYLZWLJ[VKLSVZ SVZWHYmTL[YVZJSxUPJVZ`KLSHIVYH[VYPVLULZ[VZ
JHTIPVZLUSH]PYLTPH3HYLK\JJP}UKLSHJHYNH WHJPLU[LZHSPUPJPHYSHTHUPMLZ[HJP}UKLSZxUKYV-
]PYHSWVYKLIHQVKLJVWPHZT3ZLHZVJPHJVU TLKLYLJVUZ[P[\JP}UPUT\UP[HYPH
TH`VYK\YHJP}UKLSHZ\WYLZP}UKLSHYLWSPJHJP}U
]PYHS ,S UHKPY V W\U[V TmZ IHQV HSJHUaHKV LZ (KLTmZ KL JVUVJLY J}TV X\LKH LS LZ[HKV
PTWVY[HU[LWHYHKLÄUPYLSYPLZNVKLYLIV[LKLSH PUT\UVS}NPJVKLLZ[VZWHJPLU[LZWVY[VTHYKL
JHYNH]PYHS`SHWVZPIPSPKHKKLYLZPZ[LUJPHZ WVY]PKHHU[PYYL[YV]PYHSLZLZPTWVY[HU[LLZ[\KPHY
[VKVZLZ[VZL]LU[VZPUT\UVS}NPJVZ`HStYNPJVZKL
DISCUSIÓN SVZKPZ[PU[VZHU[PYYL[YV]PYHSLZL_PZ[LU[LZHZxJVTV
SHYLZW\LZ[HWHY[PJ\SHYKLSVZWHJPLU[LZWVYSV
(WLZHYKLZHILYX\LLSWYVWPV[YH[HTPLU[VJVU X\LLULSSVZLZULJLZHYPVJVU[PU\HYYLHSPaHUKV
HU[PYYL[YV]PYHSLZ WYV]VJH LMLJ[VZ PUKLZLHISLZ LZ[\KPVZ`\UTPU\JPVZVZLN\PTPLU[VJSxUPJV
` [}_PJVZ LU LS M\UJPVUHTPLU[V KL KP]LYZVZ
}YNHUVZ LS TtKPJV [YH[HU[L KL WHJPLU[LZ JVU REFERENCIAS
=0/ LU]xH H SVZ HSLYN}SVNVZ H LZ[VZ WHJPLU[LZ
WHYH ZHILY ZP SHZ SLZPVULZ X\L THUPÄLZ[HU LU 1. Kelze >, Pilloǁ d. PhenLJtoin-induced drug reacƟon ǁith
eosinophilia and sLJstemic sLJmptoms ;DRSSͿ sLJndrome:
SH WPLS WVY LQLTWSV LYP[YVKLYTPH ` L_HU[LTH A case report from the emergency department. J Emerg
TmJ\SVWHW\SHY NLULYHSPaHKV ZVU JH\ZHKHZ Med 2013;44:75-78.
WVY WYVISLTHZ KL [PWV HStYNPJV HS HU[PYYL[YV]P- 2. ,arr d, French >E. Severe cutaneous adverse reacƟons: acu-
ral,WLYVHKLTmZHSN\UVZKLLZ[VZWHJPLU[LZ te generalized exanthematous pustulosis, toxic epidermal
necrolysis and Stevens-Johnson syndrome. Med Clin North
W\LKLUWHKLJLYLSZxUKYVTLKLYLJVUZ[P[\JP}U
Am 2010;94:727-742.
PUT\UVS}NPJHLULSX\LZLOHLUJVU[YHKVX\L
3. Cacoub P, MuseƩe P, Descamps V, Meyer K, et al. dhe DRESS
LU T\JOVZ WHJPLU[LZ ZVIYL [VKV LU Z\QL[VZ syndrome: a literature revieǁ. Am J Med 2011;124:588-
JVU IHQVZ YLJ\LU[YVZ KL JtS\SHZ *+ HU[LZ 597.
KL LTWLaHY LS [YH[HTPLU[V HU[PYYL[YV]PYHS SVZ 4. Chamizo-López FJ, Gilarranz-Luengo R, Hernández-Febles M,
ZxU[VTHZ X\L THUPÄLZ[HU LZ[mU YLSHJPVUHKVZ Pena-López MJ. dransmission of anƟretroviral drug resistant
strains in paƟents diagnosed ǁith human immunodeĮcien-
JVU \UH YLWHYHJP}U KLS ZPZ[LTH PUT\UP[HYPV V cy virus infecƟon in Gran Canaria in the period 2009-2012.
YLJVUZ[P[\JP}UPUT\UVS}NPJHJVTVYLZ\S[HKVKLS Enferm Infecc Microbiol Clin 2014;32:695-696.
Revista Alergia México Volumen 62, Núm. 2, abril-junio 2015
5. Ramiro MA, Llibre JM. Legal, ethical, and economic impli- 10. dorres HA, Rallapalli V, Saxena A, Granǁehr , et al. Eĸcacy
caƟons of breaŬing doǁn once-daily Įxed-dose anƟretro- and safety of anƟretrovirals in HIV-infected paƟents ǁith
viral combinaƟons into their single components for cost cancer. Clin Microbiol Infect 2014. [Epub ahead of print].
reducƟon. Enferm Infecc Microbiol Clin 2014;32:598-602. 11. Rubinstein PG, AboulaĮa DM, Zloza A. Malignancies in HIVͬ
6. Sánchez y, Merlano C, Cruz C. Drug rash ǁith eosinophilia AIDS: From epidemiology to therapeuƟc challenges. AIDS
and systemic symptoms ;DRESSͿ. Rev Asoc Col Dermatol 2014;28:453-465.
2008;16:208-210. 12. Nayadu S<, alar . Colorectal cancer screening in human
7. Fobelo Lozano MJ. AnƟretroviral therapy. DetecƟon of immunodeĮciency virus populaƟon: Are they at average
adverse drug reacƟons from hospital admission diagnoses. risŬ͍ torld J Gastrointest Kncol 2012;15:259-264.
Farmacia Hospitalaria 1999;23:337-342. 13. Vaũdic CM, van Leeuǁen Md. that types of cancers are
8. Moya z, ernal F, Roũas E, arthel E. PharmaceuƟcal folloǁ associated ǁith immune suppression in HIV͍ Lessons
up of anƟrretroviral treatment in outpaƟents. Rev Chil from solid organ transplant recipients. Curr Kpin HIV AIDS
Infectol 2012;29:412-419. 2009;4:35-41.
9. Sharma M, talmsley SL. Raltegravir as anƟretroviral the- 14. talŬty A, Smith D, LopŬo RN, et al. Severe sŬin rash as-
rapy in HIVͬAIDS. Expert Kpin Pharmacother 2014;15:395- sociated ǁith atazanavir. Can J Infect Dis Med Microbiol
405. 2009;20:e10-e12.